DEFPROC

Active

Goods

Drugs and Pharmaceutical Products

CHAFB/8703/LTE-282

Indian Air Force

MED PROC CELL, CHAFB | Bengaluru Urban, Karnataka

Amount: Refer DocsCloses: 10 Sept 2026Due tomorrow

Timeline

Published5 Sept 2026
Closes10 Sept 2026
Bid Opening11 Sept 2026

Tender Value

Refer Docs

Closing Date

10 Sept 2026, 12:20 pmDue tomorrow

Tender Inviting Organisation

Name

OIC MED PROC CELL

Address

MED PROC CELL , CHAFB

Work Description

PROCUREMENT OF INJ OCRELIZUMAB 300MG 10ML

Tender Information

Tender ID

2026_IAF_787547_1

Reference Number

CHAFB/8703/DRUG/LTE

Tender Type

Open Tender

Product Category

Drugs and Pharmaceutical Products

Form of Contract

Buy

Location

MED PROC CELL, CHAFB

Source Website

Subscribe to view

Eligibility / Pre-Qualification

Please refer Tender documents.

Documents Required

2 documents required · 2 mandatory

Fee/PreQual/Technical

RequiredRFP (.pdf)

Finance

RequiredBOQ (.xls)

Fee & Financial Details

Tender Fee Amount

₹0

EMD Fee Amount

Exempted

Important Dates

Last Activity

5 Sept 2026

Published

5 Sept 2026

Bid Opening

11 Sept 2026

Download Starts

5 Sept 2026

Download Ends

10 Sept 2026

Submission Starts

5 Sept 2026

Clarification Period

5 Sept 2026 - 9 Sept 2026

Bill of Quantities

Item WiseBoQ_Ver3.0INR

BoQ1 (1 items)

Sl No	Description	Qty	Unit	Est. Rate	Est. Amount
1.01	INJ OCRELIZUMAB 300MG/10ML	2	VIAL	-	-

Documents

Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.

Tender Page Snapshot

details.html

html • 0.03 MB

NIT Documents

Tendernotice_1.pdf

PDF • 8.18 MB

Work Item Documents

BOQ_883128.xls

BOQ • 1.68 MB

Ready to Participate?

Download all tender documents and submit your bid

Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .